Furthermore, after autologous stem cell transplantation, one of the most efficacious therapies in MS by resetting the immune system, the reestablished CD8+ T cell repertoire contains clones already present before treatment, while the CD4+ T cell repertoire was reset by newly generated clones (19). Here, CD8A is linked to myeloid sarcoma.